Literature DB >> 8676491

A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells.

S Zolotukhin1, M Potter, W W Hauswirth, J Guy, N Muzyczka.   

Abstract

We constructed gfph, a synthetic version of the jellyfish Aequorea victoria green fluorescent protein (gfp) cDNA that is adapted for high-level expression in mammalian cells, especially those of human origin. A total of 92 base substitutions were made in 88 codons in order to change the codon usage within the gfp10 coding sequence so that it was more appropriate for expression in mammalian cells. We also describe a series of versatile recombinant adeno-associated virus and adenovirus vectors for delivery and expression of genes into mammalian cells and, using these vectors, demonstrate the efficient transduction and expression of the gfph gene in the human cell line 293 and also in vivo, within neurosensory cells of guinea pig eye. Cells infected with recombinant adeno-associated virus-GFPH can be readily sorted by fluorescence-activated cell sorting, suggesting that the newly designed gfph gene could be widely used as a reporter in many gene delivery technologies, including human gene therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8676491      PMCID: PMC190401     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

Review 1.  Use of adeno-associated virus as a general transduction vector for mammalian cells.

Authors:  N Muzyczka
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

2.  Downstream secondary structure facilitates recognition of initiator codons by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

Review 3.  The novel mechanism of initiation of picornavirus RNA translation.

Authors:  R J Jackson; M T Howell; A Kaminski
Journal:  Trends Biochem Sci       Date:  1990-12       Impact factor: 13.807

4.  Sequences required for coordinate induction of adeno-associated virus p19 and p40 promoters by Rep protein.

Authors:  D M McCarty; M Christensen; N Muzyczka
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  Internal initiation of translation mediated by the 5' leader of a cellular mRNA.

Authors:  D G Macejak; P Sarnow
Journal:  Nature       Date:  1991-09-05       Impact factor: 49.962

6.  At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells.

Authors:  M Kozak
Journal:  J Mol Biol       Date:  1987-08-20       Impact factor: 5.469

7.  A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5.

Authors:  W J McGrory; D S Bautista; F L Graham
Journal:  Virology       Date:  1988-04       Impact factor: 3.616

8.  Correlation between the abundance of yeast transfer RNAs and the occurrence of the respective codons in protein genes. Differences in synonymous codon choice patterns of yeast and Escherichia coli with reference to the abundance of isoaccepting transfer RNAs.

Authors:  T Ikemura
Journal:  J Mol Biol       Date:  1982-07-15       Impact factor: 5.469

9.  Primary structure of the Aequorea victoria green-fluorescent protein.

Authors:  D C Prasher; V K Eckenrode; W W Ward; F G Prendergast; M J Cormier
Journal:  Gene       Date:  1992-02-15       Impact factor: 3.688

10.  Chemical structure of the hexapeptide chromophore of the Aequorea green-fluorescent protein.

Authors:  C W Cody; D C Prasher; W M Westler; F G Prendergast; W W Ward
Journal:  Biochemistry       Date:  1993-02-09       Impact factor: 3.162

View more
  170 in total

1.  Kinetics of recombinant adeno-associated virus-mediated gene transfer.

Authors:  A K Malik; P E Monahan; D L Allen; B G Chen; R J Samulski; K Kurachi
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Retroviral inhibition of cAMP-dependent protein kinase inhibits myelination but not Schwann cell mitosis stimulated by interaction with neurons.

Authors:  D G Howe; K D McCarthy
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

3.  Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents.

Authors:  M Marschall; M Freitag; S Weiler; G Sorg; T Stamminger
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

4.  CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts.

Authors:  C Hidaka; E Milano; P L Leopold; J M Bergelson; N R Hackett; R W Finberg; T J Wickham; I Kovesdi; P Roelvink; R G Crystal
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

Review 5.  Designing antisense to inhibit the renin-angiotensin system.

Authors:  D Mohuczy; M I Phillips
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 6.  Reporter gene vectors and assays.

Authors:  E Schenborn; D Groskreutz
Journal:  Mol Biotechnol       Date:  1999-11       Impact factor: 2.695

7.  Involvement of cellular double-stranded DNA break binding proteins in processing of the recombinant adeno-associated virus genome.

Authors:  L Zentilin; A Marcello; M Giacca
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

8.  TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo.

Authors:  Li Cheng; Przemyslaw Sapieha; Pavla Kittlerova; William W Hauswirth; Adriana Di Polo
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

9.  The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells.

Authors:  Mark Cannon; Nicola J Philpott; Ethel Cesarman
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  Iron Deficiency Impairs Developing Hippocampal Neuron Gene Expression, Energy Metabolism, and Dendrite Complexity.

Authors:  Thomas W Bastian; William C von Hohenberg; Daniel J Mickelson; Lorene M Lanier; Michael K Georgieff
Journal:  Dev Neurosci       Date:  2016-09-27       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.